Cullis PR - Search Results

1

Small molecule ligands for enhanced intracellular delivery of lipid nanoparticle formulations of siRNA.

Tam YY, Chen S, Zaifman J, Tam YK, Lin PJ, Ansell S, Roberge M, Ciufolini MA, Cullis PR. Tam YY, et al. Among authors: cullis pr. Nanomedicine. 2013 Jul;9(5):665-74. doi: 10.1016/j.nano.2012.11.006. Epub 2012 Dec 6. Nanomedicine. 2013. PMID: 23219877

2

Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjugation of proteins to liposomes.

Harasym TO, Tardi P, Longman SA, Ansell SM, Bally MB, Cullis PR, Choi LS. Harasym TO, et al. Among authors: cullis pr. Bioconjug Chem. 1995 Mar-Apr;6(2):187-94. doi: 10.1021/bc00032a006. Bioconjug Chem. 1995. PMID: 7599262

3

Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles.

Parr MJ, Ansell SM, Choi LS, Cullis PR. Parr MJ, et al. Among authors: cullis pr. Biochim Biophys Acta. 1994 Oct 12;1195(1):21-30. doi: 10.1016/0005-2736(94)90004-3. Biochim Biophys Acta. 1994. PMID: 7918562

4

Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids.

Hafez IM, Ansell S, Cullis PR. Hafez IM, et al. Among authors: cullis pr. Biophys J. 2000 Sep;79(3):1438-46. doi: 10.1016/S0006-3495(00)76395-8. Biophys J. 2000. PMID: 10969005 Free PMC article.

5

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

de Jong S, Chikh G, Sekirov L, Raney S, Semple S, Klimuk S, Yuan N, Hope M, Cullis P, Tam Y. de Jong S, et al. Cancer Immunol Immunother. 2007 Aug;56(8):1251-64. doi: 10.1007/s00262-006-0276-x. Epub 2007 Jan 23. Cancer Immunol Immunother. 2007. PMID: 17242927 Free PMC article.

6

Effects of intravenous and subcutaneous administration on the pharmacokinetics, biodistribution, cellular uptake and immunostimulatory activity of CpG ODN encapsulated in liposomal nanoparticles.

Wilson KD, Raney SG, Sekirov L, Chikh G, deJong SD, Cullis PR, Tam YK. Wilson KD, et al. Among authors: cullis pr. Int Immunopharmacol. 2007 Aug;7(8):1064-75. doi: 10.1016/j.intimp.2007.04.002. Epub 2007 May 2. Int Immunopharmacol. 2007. PMID: 17570323

7

The effect of circulation lifetime and drug-to-lipid ratio of intravenously administered lipid nanoparticles on the biodistribution and immunostimulatory activity of encapsulated CpG-ODN.

Raney SG, Wilson KD, Sekirov L, Chikh G, de Jong SD, Cullis PR, Tam YK. Raney SG, et al. Among authors: cullis pr. J Drug Target. 2008 Aug;16(7):564-77. doi: 10.1080/10611860802228756. J Drug Target. 2008. PMID: 18686126

8

The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine.

Wilson KD, de Jong SD, Kazem M, Lall R, Hope MJ, Cullis PR, Tam YK. Wilson KD, et al. Among authors: cullis pr. J Gene Med. 2009 Jan;11(1):14-25. doi: 10.1002/jgm.1267. J Gene Med. 2009. PMID: 19003796

9

Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.

Chikh G, de Jong SD, Sekirov L, Raney SG, Kazem M, Wilson KD, Cullis PR, Dutz JP, Tam YK. Chikh G, et al. Among authors: cullis pr. Int Immunol. 2009 Jul;21(7):757-67. doi: 10.1093/intimm/dxp044. Epub 2009 Jun 5. Int Immunol. 2009. PMID: 19502586

10

Synthesis of a labeled RGD-lipid, its incorporation into liposomal nanoparticles, and their trafficking in cultured endothelial cells.

Cressman S, Dobson I, Lee JB, Tam YY, Cullis PR. Cressman S, et al. Among authors: cullis pr. Bioconjug Chem. 2009 Jul;20(7):1404-11. doi: 10.1021/bc900041f. Bioconjug Chem. 2009. PMID: 19534457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters